Stay updated on TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.

Latest updates to the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedShow glossary was added, and the footer now includes Last Update Submitted that Met QC Criteria and No FEAR Act Data with Revision: v3.4.0. Older wording of Last Update Submitted that met QC Criteria, No FEAR Act data, and the previous Revision: v3.3.4 were removed.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.3.4 is displayed, replacing the previous revision: v3.3.3.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's Locations section was updated to add new sites across multiple countries and regions and to remove several existing sites. A version note Revision: v3.3.3 was added.SummaryDifference3%

- Check67 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; no changes to core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page update removes a generic government funding operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to TAK-861 Study in Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 Study in Narcolepsy Type 2 Clinical Trial page.